Adjusting Objective Correction Collar on ImageXpress Micro

| February 3, 2017

article image
In this "how-to" video, users of the ImageXpress Micro System will learn ways to adjust the correction collar on the objective to accommodate for different plate bottom or slide thicknesses, thus ensuring optimal image quality.

Spotlight

Greentech

The biotechnology, source of beauty and wellness Pionner in plant biotechnology, GREENTECH develops and produces for cosmetic, pharmaceutical and nutraceutical fields high tech active ingredients from plants, marine and microbial worlds. From the heart of the plant to the heart of the skin, an endless source of actives of proven efficacy. The R&D laboratory has got its own large database (30 000 plants – 300 000 biological molecules) and uses bio-informatics for rapid and targeted development of new actives. First company to supply cosmetic ingredients certified Organic by ECOCERT (France), today, GREENTECH is one of the largest suppliers of Organic ingredients. For many years, GREENTECH has got close and official cooperation with local people in different countries with spirit of sustainable development and trade with important benefits: protection of biodiversity, improvement of local knowledge, economical benefits for local population, respect of local way of life.

OTHER ARTICLES

Wisconsin biotech companies could play key roles in long-term economic recovery from COVID-19 pandemic

Article | April 19, 2020

Whether it’s called a modern “Manhattan Project” or a medical moon shot, the concept of long-term economic recovery rests on how confident people are they won’t risk serious illness by venturing forth in public again. Wisconsin stands to be a significant part of such an undertaking, whatever it’s called. The shorter-term debate is well under way over the gradual lifting of COVID-19 emergency rules, such as the now-extended “safer-at-home” order in Wisconsin. At least a dozen states, including regional coalitions on the East and West coasts, are exploring next steps as they seek to balance responses to the virus with calls for reopening the economy, at least, in part. Wisconsin’s ability to shape longer-term responses will come from private and public resources, which range from companies engaged in production of diagnostics.

Read More

5 Biotech Stocks Winning the Coronavirus Race

Article | April 13, 2020

There are quite a few companies that have found ways to grow their business during the ongoing COVID-19 pandemic. This is especially true for a number of biotechs now working on developing a potential treatment for, or vaccine against, the virus; shares of such companies have largely surged over the past couple of months. Although many of these treatments and vaccines are still have quite a way to go before they're widely available, it's still worth taking some time to look through what's going on in the COVID-19 space right now. Here are five biotech stocks that are leading the way when it comes to addressing COVID-19. Regeneron Pharmaceuticals (NASDAQ:REGN) wasn't among the initial wave of companies to announce a potential COVID-19 drug. However, investor excitement quickly sent shares surging when the company announced that its rheumatoid arthritis drug, Kevzara, could help treat COVID-19 patients.

Read More

Defense biotech research looks to eliminate bacteria causing traveler’s diarrhea, reduce jet lag duration

Article | April 9, 2020

World traveler‘s will rejoice at the idea of a seemingly magical device that would guarantee they never suffer from the all-too-familiar stomach issues that come from traveling internationally while reducing jet lag at the same time. But it’s not just privileged globetrotters that would benefit from a device that eliminates the bacteria associated with the so-called Montezuma’s Revenge. In 2016, more than 230,000 children around the world died from some of the same types of bacteria as those that cause traveler’s diarrhea, and the bacteria mainly come from unsafe “drinking water, poor sanitation and malnutrition,” according to Oxford University’s Our World In Data portal. On Monday, DARPA announced it was researching an “implantable or ingestible bioelectronic carrier” that would eliminate the five major bacteria associated with traveler’s diarrhea.

Read More

Pfizer, BioNTech Plan Clinical Trial for COVID-19 mRNA Vaccine Candidate

Article | April 9, 2020

Pfizer and BioNTech plan to begin human clinical trials on their lead COVID-19 therapeutic candidate, an mRNA vaccine, by the end of this month, the companies said today, through a collaboration that could generate up to $748 million for the German biotech. The companies announced plans last month to partner on BNT162, the first treatment to emerge from BioNTech’s accelerated COVID-19-focused development program, “Project Lightspeed.” BioNTech and Pfizer established collaboration intended to draw upon BioNTech’s proprietary mRNA vaccine platforms, and Pfizer’s expertise in vaccine research and development, regulatory capabilities, and global manufacturing and distribution network.

Read More

Spotlight

Greentech

The biotechnology, source of beauty and wellness Pionner in plant biotechnology, GREENTECH develops and produces for cosmetic, pharmaceutical and nutraceutical fields high tech active ingredients from plants, marine and microbial worlds. From the heart of the plant to the heart of the skin, an endless source of actives of proven efficacy. The R&D laboratory has got its own large database (30 000 plants – 300 000 biological molecules) and uses bio-informatics for rapid and targeted development of new actives. First company to supply cosmetic ingredients certified Organic by ECOCERT (France), today, GREENTECH is one of the largest suppliers of Organic ingredients. For many years, GREENTECH has got close and official cooperation with local people in different countries with spirit of sustainable development and trade with important benefits: protection of biodiversity, improvement of local knowledge, economical benefits for local population, respect of local way of life.

Events